All authors are affiliated with the Department of Plastic and Reconstructive Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Dermatol Surg. 2020 Nov;46(11):e88-e95. doi: 10.1097/DSS.0000000000002341.
Treatment of the aging midface is increasingly deemed a key part of facial and periorbital rejuvenation. Compared with Westerners, Asians tend to have a relatively prominent zygoma and mandibular angle, thicker dermis, and greater propensity for scar formation.
This study was performed to review our surgical method of vertical midface lifting in Asian patients and evaluate the clinical outcomes.
This retrospective observational study involved 116 Asian women who complained of an aged midface. All patients underwent midface rejuvenation surgery with one lower eyelid incision and 2 small frontal-temporal incisions. Clinical results were assessed objectively using photographs and subjectively by a patient satisfaction survey.
All patients recovered well without major complications. High patient satisfaction (94%) was attained. The improvement scores as evaluated by the panel demonstrated a higher level of improvement for the malar eminence (8.3 ± 0.6), nasojugal groove (8.0 ± 0.8), and nasolabial fold (7.9 ± 0.7) than for the lower face (6.2 ± 1.0).
Our vertical midface lift technique is safe and effective for older Asian patients with a midface aging appearance.
Therapeutic IV.
治疗中面部衰老已逐渐被视为面部和眶周年轻化的关键部分。与西方人相比,亚洲人颧骨和下颌角相对突出,真皮较厚,瘢痕形成倾向较大。
本研究旨在回顾我们对亚洲患者行垂直中面部提升术的手术方法,并评估其临床效果。
这是一项回顾性观察研究,共纳入 116 名抱怨中面部衰老的亚洲女性。所有患者均通过下眼睑切口和 2 个小的额颞部切口行中面部年轻化手术。通过照片从客观和患者满意度调查从主观两方面评估临床效果。
所有患者均恢复良好,无重大并发症。患者满意度高达 94%。由专家组评估的改善评分显示,颧骨突出(8.3±0.6)、鼻颊沟(8.0±0.8)和鼻唇沟(7.9±0.7)的改善程度高于下面部(6.2±1.0)。
我们的垂直中面部提升技术对于中面部老化的老年亚洲患者是安全有效的。
治疗性 IV 级。